Israeli biotech company Clearmind Medicine Inc CEO Dr. Adi Zuloff-Shani addresses letter to shareholders
Clearmind Medicine Inc. Tel Aviv, Israel / Vancouver, Canada, Dec. 15 2022 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq, CSE: CMND) (FSE: CWY) (“Clearmind” or the “Company”)a biotechnology company developing therapies derived from psychedelics, has released the following letter to shareholders from its CEO, Dr. Adi Zuloff-Shani. Dear shareholders, Clearmind’s overriding mission since inception has …